Koers Easton Pharmaceuticals Inc. Other OTC
Aandelen
EAPH
US2777741057
Biotechnologie & Medisch Onderzoek
Omzet 2019 | 1,56 mln. 1,46 mln. | Omzet 2020 | - | Marktkapitalisatie | 807K 755K |
---|---|---|---|---|---|
Nettowinst (verlies) 2019 | - 0 | Nettowinst (verlies) 2020 | - 0 | EV/omzet 2019 | 6,27 x |
Nettoschuld 2019 | 8,41 mln. 7,87 mln. | Nettoschuld 2020 | 2,48 mln. 2,32 mln. | EV/omzet 2020 | - |
K/w-verhouding 2019 |
-4,17
x | K/w-verhouding 2020 |
-4,29
x | Werknemers | - |
Dividendrendement 2019 * |
-
| Dividendrendement 2020 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Evan Karras
CEO | Chief Executive Officer | - | 30-06-15 |
Vince Demasi
COO | Chief Operating Officer | - | 20-06-18 |
Chief Tech/Sci/R&D Officer | - | 01-01-15 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Evan Karras
CEO | Chief Executive Officer | - | 30-06-15 |
John Guerra
SEC | Corporate Secretary | - | 31-12-13 |
Vince Demasi
COO | Chief Operating Officer | - | 20-06-18 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+17,69% | 122 mld. | |
+19,94% | 116 mld. | |
+21,54% | 27,03 mld. | |
-21,07% | 20,36 mld. | |
-16,71% | 16,43 mld. | |
-18,30% | 15,91 mld. | |
-44,35% | 15,6 mld. | |
+63,06% | 14,94 mld. | |
+1,42% | 13,59 mld. |